Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Trial of D2 Versus D2 + Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer (14VIGTORY Trial)

NCT03264807 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT03264807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Trial of D2 Versus D2 + Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer (14VIGTORY Trial)
Lead sponsor
National Cancer Center, Korea
Phase
Phase 3
Overall status
Unknown status
Start date
August 6, 2015
Completion date
December 31, 2021
Enrollment
518 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer